MONARCH 3 Interim OS: Abemaciclib + Nonsteroidal AI as First-line Treatment for HR+/HER2- Advanced Breast Cancer

Video featuring global experts discussing the latest advances in HER2-low advanced breast cancer, including managing the use and safety of antibody–drug conjugates, from Clinical Care Options (CCO)

Nadia Harbeck, MD, PhD Komal Jhaveri, MD Heather McArthur, MD, MPH Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Released: January 19, 2023 Expired: January 18, 2024

Downloadable slideset on key points from a podcast on how to optimize personalized care of patients with TNBC, from Clinical Care Options (CCO)

Mark Pegram, MD Sara Tolaney, MD, MPH Released: January 18, 2023

On-demand Clinical Care Options (CCO) webcast: experts discuss how to optimize the personalized care of patients with TNBC

Mark Pegram, MD Sara Tolaney, MD, MPH Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: 1.0 AAPA Category 1 CME credit Released: January 12, 2023 Expired: January 11, 2024

Downloadable slides on multidisciplinary approaches to managing high-risk, HR-positive/HER2-negative early breast cancer, from Clinical Care Options, (CCO)

Erika P. Hamilton, MD
Program Director Joyce O'Shaughnessy, MD
Program Director Released: January 4, 2023